Dr. Reddy's Laboratories
RDY
#1699
Rank
$11.86 B
Marketcap
$14.19
Share price
0.35%
Change (1 day)
-1.32%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total debt

Total debt on the balance sheet as of September 2025 : $0.65 Billion USD

According to Dr. Reddy's Laboratories's latest financial reports the company's total debt is $0.65 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Dr. Reddy's Laboratories - Total debt on balance sheet (from 2001 to 2025)

Total debt by year

Year Total debt Change
2025-03-31$0.54 B127.85%
2024-03-31$0.24 B46.45%
2023-03-31$0.16 B-63.22%
2022-03-31$0.44 B7.69%
2021-03-31$0.41 B41.1%
2020-03-31$0.29 B-46.92%
2019-03-31$0.55 B-29.03%
2018-03-31$0.77 B2.72%
2017-03-31$0.75 B49.9%
2016-03-31$0.50 B-26.91%
2015-03-31$0.69 B-7.19%
2014-03-31$0.74 B10.12%
2013-03-31$0.67 B6.91%
2012-03-31$0.63 B19.46%
2011-03-31$0.53 B60.43%
2010-03-31$0.33 B-15.19%
2009-03-31$0.38 B-19.28%
2008-03-31$0.48 B-15.98%
2007-03-31$0.57 B-17.08%
2006-03-31$0.69 B966.13%
2005-03-31$65.01 M457.91%
2004-03-31$11.65 M67.89%
2003-03-31$6.94 M122.01%
2002-03-31$3.12 M-96.3%
2001-03-31$84.42 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
$60.84 B 9,134.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$17.07 B 2,491.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
$23.86 B 3,521.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
$32.02 B 4,759.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
$25.53 B 3,774.71%๐Ÿ‡ซ๐Ÿ‡ท France